Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center The licensing agreement refers to the company's dedicated treatment for cocaine addiction which previously indicated a significant decrease in cocaine craving Tel Aviv, Israel / Vancouver,...

SciSparc Ltd. Announces Initial Positive Results for the Cocaine Addiction Treatment of Clearmind Medicine Inc. TEL AVIV, Israel, June 07, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the...

Clearmind Medicine and SciSparc Collaboration Yields Another Patent Application for Cocaine Addiction Treatment No dedicated treatment currently available for cocaine addiction VANCOUVER, June 02, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the...

U.S. Cocaine Addiction Market and Competitive Landscape 2020 Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "US Cocaine Addiction Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering. The report provides...

Miami Drug Rehabs - Treated Addictions SAN DIEGO, April 29, 2018 (GLOBE NEWSWIRE) -- Miami Drug Rehabs refers to the various centers where drug addicts are being helped to turn new leaves in their lives toward becoming better persons....